Isoptin Hta

Verapamil Hydrochloride, the active ingredient in Isoptin Hta, is a calcium channel blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, chest pain from angina, and certain rapid heart rhythms in adult patients.

GNH USA supplies Isoptin Hta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution. Customers benefit from reliable lead times and comprehensive support throughout the procurement process.

Isoptin Hta, a calcium channel blocker, is indicated for several cardiovascular conditions.

Hypertension: reduces systemic vascular resistance to lower blood pressure. Angina pectoris: alleviates chest pain by decreasing myocardial oxygen demand. Supraventricular tachyarrhythmias (e.g., atrial fibrillation, atrial flutter): slows atrioventricular nodal conduction to control heart rate.

Verapamil Hydrochloride may be associated with a range of adverse reactions, which are categorised by frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Dizziness or light‑headedness: due to blood‑pressure fall. - Headache: vascular dilation. - Peripheral oedema: fluid accumulation in lower limbs.

Serious or Rare Side Effects: - Bradycardia: excessively slow heart rate. - Heart block: impaired electrical conduction. - Severe hypotension: sudden drop in blood pressure. - Hepatotoxicity: elevation of liver enzymes.

When prescribing Isoptin Hta, clinicians should consider several safety measures.

Cardiovascular assessment: evaluate heart rate and conduction before initiating therapy. Concomitant beta‑blocker use: monitor for excessive bradycardia or AV block. Liver impairment: adjust dose or monitor hepatic function. Pregnancy and lactation: use only if benefits outweigh risks. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Verapamil Hydrochloride interacts with various medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may cause toxic verapamil levels. - Digoxin: increased risk of digoxin toxicity. - Beta‑blockers: additive negative chronotropic effect.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy. - Antacids containing aluminium or magnesium: may decrease absorption. - Statins metabolised by CYP3A4 (e.g., simvastatin): increased risk of myopathy.